Emily Hawkins
Nurse Practitioner · Ocala, FLNPI 1467972695
Payments from drug & device makers
Across 207 payments — averaging $17.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$959
- Pfizer$611
- Novo Nordisk$200
- Lilly USA, LLC$185
- Amarin Pharma, Inc.$160
- Esperion Therapeutics, Inc.$156
- plus $1K from 25 others
What the payments were for
- Food & beverage$3,668100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 58 | $959 |
| Pfizer | 35 | $611 |
| Novo Nordisk | 13 | $200 |
| Lilly USA, LLC | 12 | $185 |
| Amarin Pharma, Inc. | 8 | $160 |
| Esperion Therapeutics, Inc. | 9 | $156 |
| Medtronic | 1 | $153 |
| Boston Scientific | 4 | $119 |
| Johnson & Johnson | 8 | $102 |
| Novartis | 6 | $95 |
| Edwards Lifesciences | 4 | $92 |
| GSK | 5 | $76 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $73 |
| Nestle Healthcare Nutrition Inc. | 4 | $70 |
| Eisai Inc. | 5 | $69 |
| Exact Sciences | 3 | $60 |
| Sanofi-aventis U.S. LLC | 3 | $59 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $55 |
| Boehringer Ingelheim | 3 | $50 |
| Amgen | 3 | $48 |
| Abbott | 2 | $45 |
| AstraZeneca | 3 | $44 |
| Vertex | 2 | $40 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $29 |
| Vifor Pharma, Inc. | 1 | $21 |
| Dexcom, Inc. | 1 | $20 |
| Idorsia Pharmaceuticals US Inc | 1 | $18 |
| Bayer | 1 | $17 |
| Biogen | 1 | $16 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
| Xeris Pharmaceuticals, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTERSTIM$153
How this compares
$3,668 in reported general payments places this provider in the 90th percentile of 8,290 nurse practitioner providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 41 | $56,131 |
| OzempicSemaglutide | 45 | $53,626 |
| JardianceEmpagliflozin | 21 | $36,318 |
| EliquisApixaban | 25 | $22,861 |
| FarxigaDapagliflozin Propanediol | 12 | $19,277 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 17 | $16,591 |
| QuliptaAtogepant | 13 | $12,728 |
| Tresiba Flextouch U-100Insulin Degludec | 16 | $11,210 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 21 | $7,699 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 25 | $3,748 |
| Lidocaine | 16 | $3,431 |
| Butalbital-Acetaminophen-CaffeButalb/Acetaminophen/Caffeine | 21 | $2,140 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 77 | $1,811 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 16 | $1,737 |
| Ventolin HfaAlbuterol Sulfate | 26 | $1,652 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $185 | $56,13141 claims |
| Novo NordiskOzempic | $200 | $53,62645 claims |
| Boehringer IngelheimJardiance | $50 | $36,31821 claims |
| PfizerEliquis | $611 | $22,86125 claims |
| AstraZenecaFarxiga | $44 | $19,27712 claims |
| GSKTrelegy Ellipta | $76 | $16,59117 claims |
| AbbVieQulipta, Synthroid | $959 | $14,25126 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 8,290 nurse practitioner providers in Florida.
Other nurse practitioner in Ocala
- Jolanta BaginskiClearwater$494K
- Adissa PerezWinter Park$370K
- April WessonTampa$342K
- Margarita FernandezMiami$311K
- Stephanie SimmermanNaples$283K
- Claudette WalkerPonte Vedra Beach$271K
- Lisa NodzonTampa$246K
- Ashima BahlTampa$226K
- Maya BloombergMiami$202K
- Jennifer PuleoTampa$171K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.